VERICEL CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.76 USD | +1.94% |
|
+5.51% | +28.50% |
| 20/06 | TD Cowen Initiates Vericel at Buy With $55 Price Target | MT |
| 14/06 | Vericel Insider Sold Shares Worth $1,526,350, According to a Recent SEC Filing | MT |
Chart calendar Vericel Corporation
9.4MPkCVRM9tFbpuYGJUMCEsc7J_xczzDqE-twD_b2wxs.gYXQTgsHs-loz4AyfC8vZYBTeIYd-HKtcYgyRrm9hnCCk4hDDXTFlwrU0g~0d2d8a81d9bcc61831e29928bfeee10f
Upcoming events on Vericel Corporation
Past events on Vericel Corporation
| 19/06/2024 12:00 am | Truist Securities MedTech Conference |
| 29/05/2024 07:10 pm | Leerink Partners Healthcare Crossroads Conference - Fireside Chat |
| 08/05/2024 06:00 pm | Q1 2024 Earnings Call |
| 08/05/2024 05:25 pm | Q1 2024 Earnings Release |
| 01/05/2024 06:30 pm | Annual General Meeting |
| 05/03/2024 09:40 pm | TD Cowen Health Care Conference |
| 29/02/2024 07:00 pm | Q4 2023 Earnings Call |
| 29/02/2024 06:25 pm | Q4 2023 Earnings Release |
| 12/02/2024 09:30 pm | Canaccord Genuity Musculoskeletal Conference |
| 10/01/2024 09:00 pm | JPMorgan Healthcare Conference |
| 15/11/2023 08:30 pm | Stephens Investment Conference |
| 08/11/2023 07:00 pm | Q3 2023 Earnings Call |
| 08/11/2023 06:25 pm | Q3 2023 Earnings Release |
| 12/09/2023 05:00 pm | Morgan Stanley Global Healthcare Conference |
| 02/08/2023 06:00 pm | Q2 2023 Earnings Call |
| 02/08/2023 05:25 pm | Q2 2023 Earnings Release |
| 10/05/2023 06:00 pm | Q1 2023 Earnings Call |
| 10/05/2023 05:25 pm | Q1 2023 Earnings Release |
| 03/05/2023 06:30 pm | Annual General Meeting |
| 07/03/2023 11:00 pm | Canaccord Genuity Musculoskeletal Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 118 117 0.35% | 124 124 0.17% | 156 157 -0.32% | 164 165 -0.16% | 198 197 0.01% | 240 |
|
EBITDA Million USD | Released Forecast Spread | -9,51 -10,5 9.46% | 18,6 16,7 10.99% | 29,5 32,0 -7.86% | 24,2 22,6 6.9% | 33,9 30,7 10.29% | 49,6 |
|
EBIT Million USD | Released Forecast Spread | -11,3 -11,5 2.23% | 2,37 0,04 6354.42% | -7,85 -5,61 -39.94% | -17,1 -21,4 20.3% | -6,46 -10,2 36.88% | 3,43 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,67 -10,3 5.89% | 3,04 1,05 190.64% | -7,58 -4,23 -79.37% | -16,0 -20,8 23.27% | -2,37 -7,32 67.65% | 7,38 |
|
Net income Million USD | Released Forecast Spread | -9,67 -10,4 6.9% | 2,86 0,49 479.46% | -7,47 -5,39 -38.6% | -16,7 -20,9 20.12% | -3,18 -7,63 58.28% | 5,48 |
|
EPS USD | Released Forecast Spread | -0,22 -0,23 5.04% | 0,06 0,01 700% | -0,16 -0,12 -37.93% | -0,35 -0,44 21.17% | -0,07 -0,16 56.25% | 0,12 |
| Announcement Date | 25/02/20 | 24/02/21 | 24/02/22 | 23/02/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 36,1 34,3 5.16% | 37,0 38,3 -3.39% | 38,6 39,9 -3.38% | 52,7 53,0 -0.5% | 41,0 37,4 9.76% | 45,9 42,1 9% | 45,6 45,1 0.96% | 65,0 65,0 0.03% | 51,3 49,1 4.51% | 52,6 | 56,1 | 80,4 | 63,4 | 66,6 |
|
EBITDA Million USD | Released Forecast Spread | 3,24 4,14 -21.71% | 2,77 5,20 -46.7% | 3,33 6,08 -45.32% | 14,9 13,4 10.85% | 1,70 4,72 -63.96% | 4,44 2,52 76.11% | 5,44 4,31 26.25% | 22,3 19,1 16.56% | 7,22 4,74 52.2% | 7,08 | 8,16 | 27,1 | 11,7 | 12,6 |
|
EBIT Million USD | Released Forecast Spread | -7,27 -4,55 -59.84% | -9,08 -5,95 -52.59% | -6,79 -4,91 -38.37% | 6,09 1,74 249.15% | -8,18 -7,51 -8.87% | -5,96 -7,36 19.04% | -5,06 -6,15 17.71% | 12,7 9,00 41.42% | -5,46 -5,49 0.56% | -5,11 | -2,86 | 16,9 | -0,53 | -0,01 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,09 -4,21 -68.31% | -8,96 -5,87 -52.76% | -6,56 -4,73 -38.69% | 6,62 1,77 274% | -7,50 -7,41 -1.09% | -5,02 -7,75 35.2% | -3,95 -5,99 34.12% | 14,1 9,20 53.25% | -3,86 -5,17 25.33% | -4,32 | -2,07 | 17,7 | 0,05 | 0,60 |
|
Net income Million USD | Released Forecast Spread | -7,09 -3,79 -86.99% | -8,96 -5,79 -54.89% | -6,58 -4,84 -35.96% | 5,92 1,72 244.18% | -7,50 -7,41 -1.09% | -5,02 -7,29 31.1% | -3,66 -5,75 36.38% | 13,0 8,59 51.3% | -3,86 -5,33 27.55% | -4,27 | -1,87 | 15,5 | 0,22 | 1,08 |
|
EPS USD | Released Forecast Spread | -0,15 -0,12 -28.57% | -0,19 -0,12 -55.74% | -0,14 -0,10 -37.25% | 0,13 0,04 261.11% | -0,16 -0,15 -4.35% | -0,11 -0,15 27.63% | -0,08 -0,12 34.25% | 0,26 0,17 54.76% | -0,08 -0,11 27.27% | -0,09 | -0,04 | 0,29 | 0,01 | 0,02 |
| Announcement Date | 04/05/22 | 03/08/22 | 09/11/22 | 23/02/23 | 10/05/23 | 02/08/23 | 08/11/23 | 29/02/24 | 08/05/24 | - | - | - | - | - |
| 11/07/2024 11:30 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 16/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 23/07/2024 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 11:30 am | BIOGAIA AB: Q2 2024 Earnings Release |
| 24/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 10:30 am | UCB: Q2 2024 Earnings Release |
| 26/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Vericel Corporation
| 23/05/2024 03:13 pm | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
| 14/05/2024 09:05 pm | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 14/05/2024 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
| 10/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 10/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 12:00 pm | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 09/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
| 09/05/2024 01:46 am | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VCEL Stock
- Calendar Vericel Corporation
